Year 2020 / Volume 112 / Number 3
Original
The efficacy of sorafenib in preventing hepatocellular carcinoma recurrence after resection: a systematic review and meta-analysis

201-210

DOI: 10.17235/reed.2020.6458/2019

Zhao Li, Jie Gao, Sheng-Min Zheng, Yang Wang, Xiao Xiang, Qian Cheng, Jiye Zhu,

Abstract
Introduction: hepatocellular carcinoma (HCC) recurrence after liver resection remains a major threat for patients’ survival. Sorafenib is recommended as an adjuvant treatment for patients after a liver resection. The objective of this meta-analysis was to estimate the therapeutic value of sorafenib in patients who underwent a HCC resection. Materials and methods: relevant reports were retrieved from electronic databases. All eligible studies were carefully reviewed and the required data were extracted. Outcome with regard to overall survival (OS), recurrence-free survival (RFS), recurrence rate, mortality rate, OS time (months) and RFS time (months) were analyzed. Results: nine trials were included. The results of the meta-analysis revealed that sorafenib did not exert a significant superior effect on OS (sorafenib as reference: hazard ratio [HR] = 2.15; 95% CI, 0.91-5.08, p = 0.80; control as reference: HR = 0.56; 95% CI, 0.31-1.02; p = 0.059), OS time in months (weighted mean differences [WMD] = 4.96; 95% CI, -1.21-11.13; p = 0.115) and RFS time in months (WMD = 7.58; 95% CI, -1.36-16.53; p = 0.097). Nevertheless, the use of sorafenib was associated with a significantly higher RFS (HR = 0.53; 95% CI, 0.31-0.90; p = 0.018), and a lower recurrence rate (risk ratio [RR] = 0.72; 95% CI, 0.60-0.86; p < 0.001) and mortality rate (RR = 0.74; 95% CI, 0.57-0.95; p = 0.20). Conclusion: according to the present meta-analysis, sorafenib showed a significant benefit in RFS, recurrence rate and mortality rate. The effect of sorafenib for the prevention of HCC recurrence seems to be encouraging. However, more evidence is still needed before reaching a definitive conclusion.
Share Button
New comment
Comments

12/01/2021 12:25:33
thanks


Related articles

Letter

Gastric schwannoma diagnosing gastric stromal tumor

DOI: 10.17235/reed.2023.9919/2023

Digestive Diseases Image

Endoscopic resection of a descending duodenal polyp with the string-clip traction

DOI: 10.17235/reed.2022.8915/2022

Letter

Endoscopic full-thickness resection of a gastric schwannoma

DOI: 10.17235/reed.2021.8385/2021

Letter

Endoscopic mucosal resection for cap poliposis treatment

DOI: 10.17235/reed.2020.6537/2019

Letter

Rhabdomyolysis in a patient under treatment with sorafenib

DOI: 10.17235/reed.2020.6440/2019

Letter to the Editor

Acute appendicitis after a colonic endoscopic submucosal resection

DOI: 10.17235/reed.2018.5307/2017

Letter to the Editor

Utility of neoadjuvant therapy in rectal GIST

DOI: 10.17235/reed.2017.4751/2016

Letter to the Editor

Endoscopic full-thickness resection for a gastric angioleiomyoma

DOI: 10.17235/reed.2017.4568/2016

Letter to the Editor

Primary anorectal malignant melanoma: an uncommon anorectal pathology

DOI: 10.17235/reed.2016.4347/2016

Review

New challenges in clinical research on hepatocellular carcinoma

DOI: 10.17235/reed.2015.4012/2015

Citation tools
Li Z, Gao J, Zheng S, Wang Y, Xiang X, Cheng Q, et all. The efficacy of sorafenib in preventing hepatocellular carcinoma recurrence after resection: a systematic review and meta-analysis. 6458/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 708 visits.
This article has been downloaded 269 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 21/06/2019

Accepted: 07/10/2019

Online First: 05/02/2020

Published: 05/03/2020

Article revision time: 89 days

Article Online First time: 229 days

Article editing time: 258 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology